| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_SMARCA5_0007400 | Exon-Exon | chr4:144466623-144467200 | chr4:143545470-143546047 | 237 nt | 0.3924 |
| hsa_chr4_0157600 | Intergenic-Intergenic | chr4:144466633-144474299 | chr4:143545480-143553146 | 28 nt | 0.4643 |
| hsa_SMARCA5_0007500 | Intron-Intron | chr4:144466737-144467077 | chr4:143545584-143545924 | 341 nt | 0.2903 |
| hsa_SMARCA5_0007600 | Exon-Exon | chr4:144467078-144468656 | chr4:143545925-143547503 | 375 nt | 0.3947 |
| hsa_chr4_0157700 | Intergenic-Intergenic | chr4:144469100-144471252 | chr4:143547947-143550099 | 194 nt | 0.3505 |
| hsa_chr4_0157800 | Intergenic-Intergenic | chr4:144469100-144474749 | chr4:143547947-143553596 | 780 nt | 0.3231 |
| hsa_SMARCA5_0007800 | Intron-Intron | chr4:144469737-144470931 | chr4:143548584-143549778 | 1195 nt | 0.3205 |
| hsa_chr4_0157900 | Intergenic-Intergenic | chr4:144471201-144474299 | chr4:143550048-143553146 | 85 nt | 0.4353 |
| hsa_SMARCA5_0007900 | Exon-Exon | chr4:144471219-144474305 | chr4:143550066-143553152 | 73 nt | 0.4658 |
| hsa_SMARCA5_0008000 | Exon-Exon | chr4:144471225-144474305 | chr4:143550072-143553152 | 67 nt | 0.4627 |
A study in mice demonstrated that the circSMARCA5 promotes angiogenesis by sponging SRSF1 mRNA to regulate VEGF-A [Mehta et al. DOI:10.1016/j.pneurobio.2020.101746]. A study in human bloodstains demonstrated that the circSMARCA5 exhibited linear degradation over 120 days, with its relative expression negatively correlated with bloodstain age both indoors (r=0.81) and outdoors (r=0.91), and it was incorporated into a mathematical formula for estimating the time since deposition [Wei et al. DOI:10.1016/j.forsciint.2022.111408]. A separate review noted that in human plasma, the circSMARCA5 is lower in patients with more severe coronary atherosclerosis, with an AUC of 0.589, indicating its potential as a diagnostic biomarker for stable coronary artery disease [Tian et al. DOI:10.3390/molecules26041155].